Lupus Alert Day serves a vital purpose. It encourages others to learn more about lupus, share information on social media, ...
Patients with cutaneous lupus erythematosus who used hydroxychloroquine had a significantly reduced risk of developing systemic lupus erythematosus.
After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback